Completed PHASE1 INTERVENTIONAL 1-arm NCT01640067

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS) (hNSCALS)

Intra-spinal Cord Delivery of Human Neural Stem Cells in ALS Patients: Proposal for a Phase I Study/ Trapianto Intramidollare di Cellule Staminali Neurali Umane Come Terapia Putativa Per la SLA: Proposta di un Trial Clinico di Fase I

Sponsor: Azienda Ospedaliera Santa Maria, Terni, Italy

Conditions Amyotrophic Lateral Sclerosis

Interventions Human Neural Stem Cells

Updated 5 times since 2017 Last updated: Dec 29, 2015 Started: Dec 31, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Amyotrophic Lateral Sclerosis and is currently completed. Azienda Ospedaliera Santa Maria, Terni, Italy leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Santa Maria, Terni, Italy
Azienda Ospedaliero Universitaria Maggiore della Carita
Università di Padova Italy

Data source: Azienda Ospedaliera Santa Maria, Terni, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Terni, Italy